Articles tagged with Vaccination
A new study suggests that HPV vaccination can reduce the number of cervical screens needed from 12 to just three for vaccinated women. The research also recommends seven lifetime screens for unvaccinated women.
A Kaiser Permanente study found that pregnant women who used an interactive website monitored by a clinical expert were more likely to vaccinate their children than those without access. The study suggests websites with interactive components can complement face-to-face clinical interactions and combat misinformation.
A new study in Nicaraguan children pinpoints a narrow window of antibody levels that enhances reaction to severe dengue, shedding light on the long-standing phenomenon of antibody-dependent enhancement (ADE). The findings hold important implications for vaccine development against dengue and related flaviviruses like Zika.
A recent study found that Helicobacter pylori's mutation rate is high from the beginning of infection, making it challenging to develop an effective vaccine. The bacterium's genetic diversity can also inhibit the production of antigens in a potential vaccine.
Researchers discovered a virus-like particle vaccine can prime the immune response and prevent severe respiratory disease caused by RSV vaccine. The study found immunizing mice with RSV fusion proteins before administering the FI-RSV vaccine prevented lung inflammation and eosinophil invasion.
A promising leprosy vaccine candidate, LepVax, is moving into human trials after years of research. The vaccine has been developed using cutting-edge technologies to induce protective responses against the disease.
Two Ebola vaccine candidates elicited strong and long-lasting immune responses in a randomized, placebo-controlled trial. The study found that 71% of one vaccine and 84% of another developed antibodies to the Ebola virus within a month, with antibody responses maintained for at least a year.
Researchers have discovered that the virus used in the early smallpox vaccine was closely related to horsepox, contradicting centuries-long assumptions that cowpox was used. The finding has significant implications for our understanding of vaccine development and its applications in modern medicine.
A combination of pathogen-specific, platform-based, and prototype-pathogen approaches is crucial for effective pandemic preparedness. These methods enable rapid deployment of diagnostics, treatments, and vaccines to stop outbreaks in their tracks.
A phase 1 clinical trial demonstrated the safety and ability of a new DNA-based Zika vaccine to elicit an immune response against the virus, with 100% of participants developing Zika-specific antibodies. The vaccine also showed promise in preventing infection in immunocompromised mice.
The overall annual incidence of measles in the United States remained low from 2001 to 2015, with most cases reported among unvaccinated individuals. The study suggests that failure to vaccinate may be the main driver of measles transmission, highlighting the importance of maintaining high vaccine coverage.
A large epidemiological study conducted in Québec found no link between the BCG vaccine and childhood asthma. The research team analyzed data from a comprehensive vaccination registry and public health records, adjusting for various confounders to ensure accurate findings.
Research from Aarhus University found that 29% of referred women over 18 have been prescribed psychiatric medicine before vaccination, compared to 17% for HPV vaccinated women. Women referred to HPV centers often had mental health issues before receiving the vaccine.
A new phase 2b trial of the Vi-conjugate typhoid vaccine shows high efficacy rates and reduced symptoms of typhoid disease. The vaccine has been shown to be safe and immunogenic, with a potential to halve typhoid infections in children under 2 years old.
The University of Hawaii has received a nearly $6.3 million grant to develop a heat-stable, trivalent Ebola vaccine that can protect against three related viruses in the same family. The vaccine, developed by Axel Lehrer, PhD, has the potential to speed up protection for health workers and others during outbreaks.
A potential Zika vaccine has shown to completely prevent infection, transmission from pregnant mothers to developing fetuses and protect males against testicular infection and injury. The vaccine also prevents a lowered sperm count after one vaccination.
The Serum Institute's rotavirus vaccine, ROTASIIL, demonstrated significant efficacy against severe rotavirus gastroenteritis, reducing severe diarrhea by over a third. The vaccine showed nearly 55% efficacy against the most severe cases, which can lead to dehydration, hospitalizations, and deaths.
Researchers funded by Morris Animal Foundation found that the rabies vaccine reduces mortality from all causes in dogs by 56 percent, particularly among young dogs. This non-specific protective effect may have implications for human medicine as well.
A study published in Annals of Internal Medicine found that hospital mortality rates after heart attack vary by age, with older and younger patient groups showing different outcomes. The Centers for Medicare & Medicaid Services currently only considers data for patients aged 65 or older when calculating hospital quality ratings.
A new study by Cedars-Sinai investigators reveals how staph bacteria trick the body's immune system, allowing repeated infections throughout life. The study sheds light on how to develop an effective vaccine harnessing T cells to combat the superbug MRSA.
Researchers argue that acellular vaccines' inability to prevent infections contributes to the disease's resurgence. The study highlights differences in mucosal immunity between whole-cell and acellular pertussis vaccines, which may have led to the increase in cases.
A recent study published in Paediatric and Perinatal Epidemiology found that the HPV vaccine is associated with improved fertility in some women, particularly those with a history of sexually transmitted infections. The research, led by Boston University School of Public Health, suggests that vaccinated women with an STI history have s...
Researchers at Oregon State University have identified two proteins, NGO1985 and NGO2121, as promising gonorrhea vaccine candidates. These proteins show extensive sensitivity to antimicrobial compounds, making them attractive targets for developing a vaccine.
Researchers identified a signature of five early innate immune markers correlating with antibody titers after vaccination, providing insight into VSV-based vaccine efficacy. The study's findings could lead to accelerated vaccine development and improved emergency vaccine strategies.
A study published in The Journal of Biological Chemistry reveals that bacterial toxins from E. coli can cause urinary tract infections with a different mechanism than pertussis toxin, which causes whooping cough. Understanding this diversity may help improve existing vaccines and create new ones.
A new study published in The Lancet found that the Gardasil 9 vaccine can reduce 90% of cervical cancer cases with long-term effectiveness. The vaccine was tested on over 14,000 women worldwide and showed similar safety profiles to the four-valent HPV vaccine.
A study found that vaccine-hesitant parents in California are finding physicians willing to grant medical exemptions, leading to a significant increase in MEs. The exemption percentage decreased overall, but counties with high past PBE use saw the largest increases in MEs.
A new case-control study found that the BCG vaccine protects over 50% of UK children against TB for at least 20 years after vaccination in early teenage years. The research highlights the importance of BCG in preventing the spread of disease, particularly in areas with high TB risk but low vaccination coverage.
A new study found that HPV vaccination rates are significantly lower among childhood cancer survivors compared to the general population. Most participants lacked a healthcare provider's recommendation, highlighting the need for increased communication and awareness about HPV vaccination.
Research shows that administering shingles vaccine several weeks prior to starting tofacitinib for rheumatoid arthritis results in robust immune responses. This is particularly beneficial for patients with rheumatoid arthritis who are at a higher risk of developing shingles.
Research suggests HPV vaccination rates for childhood cancer survivors are lower than the national average, but healthcare providers play a crucial role in recommending the vaccine. The study found that nearly half of survivors who received recommendations were vaccinated, compared to just 23.8% of those who did not.
Researchers have made progress toward a vaccine against fentanyl and heroin combinations, showing efficacy in monkeys. The vaccine stimulates production of antibodies that bind to the heroin molecule itself and prevent it from reaching the opioid receptor.
Researchers explore the origins of the smallpox vaccine, tracing its development from cowpox virus to modern vaccinia virus. The study sheds light on the intricate relationships between different types of viruses and lymphs involved in the vaccine's evolution.
New study confirms the sustained impact of rotavirus vaccination in reducing diarrhea hospitalizations among US children under 5, with estimated savings of $1.2 billion in direct medical costs. Researchers found that hospitalization rates decreased by between 31-55% following routine vaccine introduction in 2006.
Alaska's comprehensive hepatitis A vaccination program, established in the 1990s, has dramatically reduced the virus's presence among native peoples. The program's success is attributed to widespread vaccination requirements for school entry, resulting in an 88% decline in imported cases since 2008.
A study shows that Alaska's universal hepatitis B vaccination programme has wiped out hepatitis B infection and liver cancer cases in the state's young people. The program, introduced in the 1980s, led to a significant decrease in acute symptomatic HBV infection and liver cancer cases among Alaskan Native children, with no reported cas...
A review of clinical trials and observational studies found that cholera vaccines reduce the risk of getting cholera by 58% in adults but only 30% in children under 5. The findings could inform policymakers on how to use the vaccine, particularly in outbreak settings like Yemen.
Researchers at the University of Maryland School of Medicine are developing a vaccine to protect against Shigella and certain E. coli, leading causes of diarrheal diseases in young children and travelers. The $2.47 million grant will support translation from an animal-tested prototype to a human-ready vaccine for Phase 1 clinical trials.
A survey found that public trust in science increased after the launch of the first human trial of a Zika vaccine, with people showing greater trust in science and paying more attention to news about the Zika virus. The study suggests that regularized communication about scientific advances could bolster confidence in science.
A recent study reveals that innate lymphoid cells (ILCs) compete with T cells for a shared source of interleukin-7 (IL-7), a protein essential for their survival. This competition sheds light on the complex phenomenon of homeostasis, which supports the long-term survival of immune cells.
A 5% drop in MMR vaccinations among children ages 2-11 could triple annual measles cases and increase public health expenditures by $2.1 million per case. The study predicts sharp rises in measles cases if vaccination rates further decline, with potential outbreaks in previously well-vaccinated communities.
A study estimates a three-fold increase in national measles cases in children ages 2 to 11 with just a 5% decline in MMR vaccine coverage, resulting in 150 cases and significant economic losses. Removing non-medical personal belief exemptions for childhood vaccination may mitigate these consequences.
New research shows that Obamacare significantly improved health insurance coverage and access to care for US youth, with over half a million Latino children gaining insurance. However, disparities remain, with Latino children still more than twice as likely to lack insurance compared to white and black youth.
Two experimental vaccines demonstrate protection against Zika-related congenital damage in mice, preventing placental damage and fetal demise. Researchers observed significant reduction of Zika virus RNA in maternal, placental, and fetal tissues among vaccinated mice.
A new study shows that females vaccinated before pregnancy and infected with Zika virus while pregnant bear pups who show no trace of the virus. Two vaccines provided substantial protection against Zika infection, reducing viral genetic material in fetuses and placentas.
Researchers at the University of Texas Medical Branch have developed a Zika vaccine that can protect the developing fetus against infection and birth defects during pregnancy. The study showed that two different potential vaccines could prevent the Zika virus from infecting the fetus.
Researchers at the University of Colorado Anschutz Medical Campus discovered a process protecting against autoimmune disease also prevents the body from creating antibodies that can neutralize HIV-1. By temporarily relaxing immunological tolerance, scientists believe they may be able to elicit protective antibodies with vaccination.
More than 115,000 children under five die annually from RSV complications, with half occurring outside hospitals in developing countries. Researchers call for affordable treatments and vaccines as a priority to combat the virus.
Researchers at Cornell University discovered a new way to measure tiny amounts of antibodies in foals, helping to understand how quickly they start producing their own. This will aid in optimizing vaccination schedules for young horses.
Researchers at Stockholm University have determined the three-dimensional structure of the entire tetanus toxin protein, revealing its exact atomic positions. The discovery sheds light on how the toxin interacts with nerve cells and causes life-threatening muscle cramps and spasms.
Researchers at UTEP have been awarded a patent for a potential vaccine against Chagas disease, a life-threatening tropical illness. The vaccine, which has shown promising results in non-human primates, could provide a much-needed solution to the growing number of people infected with the disease.
A recent study by Virginia Tech researchers breaks down the ideas driving pro- and anti-vaccination stances, revealing that both sides focus on different concerns and interests. The study's findings suggest that understanding these core concepts can help address public concerns about vaccination safety.
Emergency room visits for shingles increased among patients aged 20-59 years old after vaccination, while decreases were seen in younger and older groups. Shingles-related costs rose by 111% from 2006 to 2013, with the majority attributed to middle-aged patients.
A phase 1 randomized controlled trial found an Ebola virus disease vaccine developed in Canada to be well-tolerated and effective, with high antibodies present six months after immunization. The vaccine showed no safety concerns and was well-received by participants.
A nurse-led vaccination programme significantly improves pneumococcal vaccination coverage among patients with chronic inflammatory rheumatic diseases. The study found that nursing staff accurately identified candidates for vaccination and informed them about its benefits.
Researchers at George Washington University are testing a candidate recombinant hookworm vaccine in a Phase II clinical trial. The study aims to prove the efficacy of the vaccine against hookworm infection and its potential benefits for millions of people infected worldwide.
A new study presents data from an FDA-approved clinical trial testing the generic vaccine BCG to reverse advanced type 1 diabetes. The findings suggest that BCG may induce a permanent increase in expression of genes that restore beneficial regulatory T cells (Tregs) preventing autoimmune attacks on the body's own tissue.
Dr. Jack Edwards, a leading researcher at LA BioMed, has been recognized with the Rhoda Benham Award for his continuous outstanding contributions to medical mycology. His work focuses on understanding fungal diseases, aiming to develop new anti-fungal agents and immunotherapies to prevent life-threatening infections.
Research confirms a positive correlation between HPV vaccination and increased cervical screening rates, contradicting concerns about reduced screening due to reassurance. However, vaccine cost and provider recommendations remain significant barriers to widespread adoption in the US.
The TSRI anti-heroin vaccine has been shown to neutralize heroin and its psychoactive products, blocking them from reaching the brain to cause a feeling of euphoria. Researchers believe this could help eliminate motivation for relapse in recovering addicts.